Taken together, the above data demonstrate that GLP-1(2836) acts through a molecular pathway involving the catalytic generation of cAMP from sAC in cardiac vascular cells to preserve membrane integrity and prevent apoptosis following oxidative injury
14,15 Potential Direct Effects on the Heart Although the systemic indirect effects of GLP-1RAs are well established as the primary drivers of their clinical benefit in HF, emerging preclinical and mechanistic evidence suggests GLP-1RAs may also exert some direct cardioprotective effects, as discussed below
This indication is not approved by the FDA, even though use for this purpose may be relatively common
Your healthcare provider starts the process by prescribing an eligible medication and submitting a prior authorization request on your behalf
Your safety is the priority, and the most effective path to accessing new treatments remains through your healthcare team and properly regulated clinical channels
doi:10.3390/biology14050575